BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23124575)

  • 1. Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness.
    Gross AK; Dunn SP; Feola DJ; Martin CA; Charnigo R; Li Z; Abdel-Latif A; Smyth SS
    J Thromb Thrombolysis; 2013 Feb; 35(2):147-54. PubMed ID: 23124575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity.
    Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Kostaki S; Papadopoulou M; Angelopoulou SM; Tsopozidi M; Savopoulos C; Hatzitolios AI
    Cerebrovasc Dis; 2016; 41(5-6):226-32. PubMed ID: 26795462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Aspirin and P2Y12 Response Assays in Detecting Reversal of Platelet Inhibition With Platelet Transfusion in Patients With Traumatic Brain Injury on Antiplatelet Therapy.
    Choi PA; Parry PV; Bauer JS; Zusman BE; Panczykowski DM; Puccio AM; Okonkwo DO
    Neurosurgery; 2017 Jan; 80(1):98-104. PubMed ID: 28362883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Combined Aspirin and Clopidogrel Treatment on Cancer Incidence.
    Leader A; Zelikson-Saporta R; Pereg D; Spectre G; Rozovski U; Raanani P; Hermoni D; Lishner M
    Am J Med; 2017 Jul; 130(7):826-832. PubMed ID: 28213047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative evaluation of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Dasbiswas A; Rao MS; Babu PR; Vijayvergiya R; Nayak R; Dani S; Tyagi S; Hiremath S; Patel T; Alexander T; Prakash VS; Singh DP; Yadav MK; Pathak K; Srivastava A
    J Assoc Physicians India; 2013 Feb; 61(2):114-6, 126. PubMed ID: 24471250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance--the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy.
    Neubauer H; Kaiser AF; Endres HG; Krüger JC; Engelhardt A; Lask S; Pepinghege F; Kusber A; Mügge A
    BMC Med; 2011 Jan; 9():3. PubMed ID: 21226927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria.
    Angus DC; Marrie TJ; Obrosky DS; Clermont G; Dremsizov TT; Coley C; Fine MJ; Singer DE; Kapoor WN
    Am J Respir Crit Care Med; 2002 Sep; 166(5):717-23. PubMed ID: 12204871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.
    Hsiao FY; Mullins CD; Wen YW; Huang WF; Chen PF; Tsai YW
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1043-9. PubMed ID: 21823195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies.
    Corrales-Medina VF; Suh KN; Rose G; Chirinos JA; Doucette S; Cameron DW; Fergusson DA
    PLoS Med; 2011 Jun; 8(6):e1001048. PubMed ID: 21738449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antiplatelet efficacy and tolerability of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients after percutaneous coronary intervention: a prospective, multicenter, randomized, open-label, phase IV, noninferiority trial.
    Park JB; Koo BK; Choi WG; Kim SY; Park J; Kwan J; Park CG; Kim HS
    Clin Ther; 2013 Jan; 35(1):28-37.e4. PubMed ID: 23328268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G;
    Cardiovasc Ther; 2016 Aug; 34(4):209-15. PubMed ID: 27086085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation.
    Luinstra M; Naunton M; Peterson GM; Bereznicki L
    J Clin Pharm Ther; 2010 Apr; 35(2):213-7. PubMed ID: 20456741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.
    Lin J; Han Z; Wang C; Yi X; Chai Z; Zhou Q; Huang R
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1131-1140. PubMed ID: 29804161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to dual antiplatelet therapy in patients with peripheral artery occlusive disease suffering from critical limb ischemia.
    Wand S; Baro D; Baecker C; Meybohm P; Schmitz-Rixen T; Zacharowski K; Mutlak H; Weber CF
    Clin Lab; 2014; 60(10):1601-7. PubMed ID: 25651704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study.
    Lee M; Wu YL; Saver JL; Lee HC; Lee JD; Chang KC; Wu CY; Lee TH; Wang HH; Rao NM; Ovbiagele B
    BMJ Open; 2014 Dec; 4(12):e006672. PubMed ID: 25468508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Socioeconomic Position and the Incidence, Severity, and Clinical Outcomes of Hospitalized Patients With Community-Acquired Pneumonia.
    Wiemken TL; Carrico RM; Furmanek SP; Guinn BE; Mattingly WA; Peyrani P; Ramirez JA
    Public Health Rep; 2020; 135(3):364-371. PubMed ID: 32228396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
    Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
    Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.
    Stuckey TD; Kirtane AJ; Brodie BR; Witzenbichler B; Litherland C; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Mehran R; Généreux P; Ben-Yehuda O; Simonton CA; Stone GW;
    JACC Cardiovasc Interv; 2017 Aug; 10(16):1607-1617. PubMed ID: 28780034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin.
    De Kam PJ; Luo WL; Wenning L; Ratcliffe L; Sisk CM; Royalty J; Radziszewski W; Wagner JA; Lai E
    Platelets; 2014; 25(7):480-7. PubMed ID: 24206527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.